When Were ZYNs Invented? The Full History of Nicotine Pouches
Roon Team

When Were ZYNs Invented? The Full History of Nicotine Pouches
If you're asking when were ZYNs invented, the answer stretches back further than most people realize. ZYN didn't appear out of nowhere, but if you've only noticed the slim white cans in the last year or two, you'd be forgiven for thinking so. The question of when were ZYNs invented has a longer answer than most expect, winding through decades of Scandinavian tobacco culture, a small pharmaceutical startup, and a biochemistry lab in Sweden.
Here's how a niche smokeless product became the fastest-growing nicotine category in the United States, and what comes next.
Key Takeaways
- Nicotine pouches were first created in 2008 by Swedish company Niconovum, originally as a smoking cessation product.
- ZYN was developed by Swedish Match in the early 2010s and first test-marketed in the U.S. in 2014.
- Philip Morris International acquired Swedish Match in November 2022 for roughly $16 billion.
- ZYN dominated the U.S. market with over 63% market share in 2024 and 202 million cans shipped in Q1 2025 alone.
- All major nicotine pouches share one thing: they deliver nicotine, and only nicotine. No cognitive performance ingredients, no sustained-focus stack, no alternative for people who never wanted nicotine in the first place.
Before ZYN: Swedish Snus and the Birth of Tobacco-Free Pouches
The history of ZYN starts long before ZYN existed. Swedish farmers in the 1700s began tucking small pouches of moistened tobacco leaves under their upper lip, a practice that became known as snus. For centuries, snus remained a Scandinavian staple, a smokeless way to consume tobacco that never caught on broadly outside of Sweden and Norway. Understanding this ZYN history means going back to these roots.
The real shift happened in the early 2000s. A Swedish pharmaceutical company called Niconovum, founded by nicotine researcher Karl Olov Fagerström, started developing something new: a pouch that delivered nicotine without any tobacco leaf. According to Niconovum's own site, the company launched its product, Zonnic, in the autumn of 2008, making it the first tobacco-free nicotine pouch in the world.
Zonnic was positioned as a medicinal nicotine replacement product with 2 mg of nicotine per pouch. It was a clinical tool, not a lifestyle product. That distinction matters when exploring when were ZYNs invented, because Zonnic set the stage for everything that followed.
In 2009, RJ Reynolds (later British American Tobacco) acquired Niconovum, bringing the concept to a much larger audience and opening the door for competitors.
Who Invented ZYN? The Swedish Match Story
So who invented ZYN? Swedish Match, Scandinavia's largest snus manufacturer, saw the potential in tobacco-free pouches and started developing its own version. According to Vaping360, ZYN was developed by biochemists Mattias Sharpe-Sjöberg and Linus Mealey in the early 2010s. Knowing who invented ZYN helps explain the product's Scandinavian DNA and its connection to centuries of snus tradition.
ZYN was first test-marketed in the U.S. in 2014, starting in Colorado. By 2016, the product had expanded to several western U.S. states and also launched in Sweden. The early rollout was small and deliberate. Swedish Match wasn't trying to create a viral product. They were testing whether Americans would accept a tobacco-free pouch format that had only ever worked in Scandinavia.
They would. And then some.
The timing was right. American consumers were already moving away from cigarettes, and vaping had primed the market for alternative nicotine delivery. ZYN offered something vaping couldn't: zero vapor, zero smell, zero visible evidence of use. You could pop one in during a meeting and nobody would know. For anyone researching when were ZYNs invented, this 2014 U.S. launch marks the true beginning of the brand's commercial life.
Between 2017 and 2019, Swedish Match invested $115 million to expand its Owensboro, Kentucky plant to manufacture ZYN directly in the U.S. By the end of 2018, ZYN was available in about 13,500 American stores. By the end of 2020, that number hit 100,000.
The ZYN Explosion: From Niche to Cultural Phenomenon
The growth numbers tell the ZYN history better than any marketing copy could.
| Year | ZYN Cans Sold (U.S.) | Notable Milestone |
|---|---|---|
| 2018 | 12.7 million | First profitable year in U.S. snus/pouch segment |
| 2019 | 50.4 million | Nearly 4x growth year-over-year |
| 2020 | ~130 million | Available in 100,000 U.S. stores |
| 2021 | ~198 million | Continued rapid expansion |
| 2022 | ~237 million | Philip Morris acquires Swedish Match |
| 2023 | 384.8 million (global) | 62% increase over 2022 |
| Q1 2025 | 202 million (U.S. only) | 53% year-over-year increase |
Sources: Wikipedia (Zyn), Fortune, Sherwood News
In November 2022, Philip Morris International completed its acquisition of Swedish Match, paying roughly $16 billion for the company. The deal was driven almost entirely by ZYN's growth trajectory. PMI had already acquired AG Snus (makers of the Shiro brand) in 2021, but quickly discontinued Shiro in 2023 to focus resources on ZYN.
By January 2025, the FDA authorized marketing of 20 ZYN nicotine pouch products after an extensive scientific review, making ZYN the first nicotine pouch brand to receive such authorization. That regulatory stamp further cemented its dominance. Looking back at when were ZYNs invented just over a decade ago, this FDA milestone shows how rapidly the brand matured.
ZYN's cultural moment was impossible to ignore. The pouches became a fixture among Gen Z professionals and gained traction as a discreet, odorless alternative to cigarettes and vaping. Philip Morris invested over $800 million in production expansion during 2023 and 2024, and in July 2024 announced plans for a second U.S. manufacturing facility in Aurora, Colorado.
The Competitive Field: ZYN vs. VELO vs. On! vs. Rogue
ZYN wasn't alone for long. By 2019, several competitors had entered the U.S. nicotine pouch market. Here's how the major players compare:
| Feature | ZYN | VELO | On! | Rogue |
|---|---|---|---|---|
| Owner | Philip Morris (Swedish Match) | British American Tobacco | Altria (Helix Innovations) | Swisher International |
| U.S. Launch | 2014 | 2019 | 2019 | 2019 |
| Nicotine Strengths | 3mg, 6mg | 2mg to 7mg (varies by market) | 1.5mg, 2mg, 4mg, 8mg | 3mg, 6mg |
| Nicotine Type | Nicotine bitartrate dihydrate (nicotine salt) | Tobacco-derived or synthetic nicotine | Tobacco-derived nicotine | Nicotine polacrilex |
| Key Ingredients | Hydroxypropyl cellulose, microcrystalline cellulose, maltitol, gum arabic, acesulfame K | Cellulose, acesulfame K, sucralose | Cellulose, sodium alginate, acesulfame K | Hydroxypropyl cellulose, microcrystalline cellulose, maltitol, acesulfame K |
| Flavors | ~10 (mint-heavy) | 30+ (wide variety) | 7 (mint, citrus, berry, coffee, cinnamon) | ~10 (fruit-forward) |
| FDA Authorized | Yes (Jan 2025) | No | Partially (On! Plus, 2025) | No |
Sources: Nicokick, Vaping360, Altria Science, CSP Daily News
Every one of these products does the same fundamental thing: deliver nicotine through the oral mucosa. The history of ZYN and its competitors shows that formulations differ slightly (nicotine salt vs. nicotine polacrilex, different sweeteners, different filler agents), but the active experience is nearly identical. You get nicotine. That's it.
The competitive differences boil down to flavor selection, pouch texture, and nicotine strength options. On! offers the widest strength range (five levels from 1.5mg to 8mg). VELO has the broadest flavor catalog with 30+ options across markets. Rogue leans into fruit flavors where ZYN focuses on mint. But strip away the branding, and these are all the same product category delivering the same single active compound.
What's Missing from Every Nicotine Pouch on the Market
Here's where understanding when were ZYNs invented becomes relevant to anyone who isn't actually looking for nicotine.
The entire nicotine pouch category, from ZYN to VELO to On! to Rogue, was designed to solve one problem: deliver nicotine without tobacco leaf. That's a meaningful improvement over cigarettes and traditional snus. But it also means every product in the category shares the same set of limitations:
1. Nicotine is the only active ingredient. None of these pouches contain anything designed to support sustained cognitive performance. The "focus" that nicotine users report is a short-term stimulant effect that fades as tolerance builds.
2. Tolerance is built into the model. Nicotine is well-documented to produce tolerance, meaning you need more over time to get the same effect. This is why ZYN, VELO, and On! all offer multiple strength levels. The product category essentially assumes you'll escalate.
3. The crash-and-jitter cycle. Nicotine's stimulant effects come with a well-known downside: a sharp drop-off that can leave you irritable, unfocused, and reaching for the next pouch. The half-life of nicotine is roughly two hours, which means you're on a constant re-dosing loop.
4. No complementary ingredients. None of the major nicotine pouches include L-Theanine (which smooths out stimulant jitters), Theacrine (which provides alertness without tolerance buildup), or Methylliberine (which extends the duration of focus). The formulations are nicotine plus filler, sweetener, and flavoring. Nothing more.
5. Dependency by design. Nicotine is one of the most addictive substances known. Every pouch in this category creates a dependency loop that keeps you buying. That's not a conspiracy theory. It's the business model.
For someone who actually wants better focus, cleaner energy, and sustained cognitive performance without building a chemical dependency, the entire nicotine pouch market has a structural gap. The full history of ZYN makes this clear: the format evolved, but the core ingredient never did.
When Were ZYNs Invented, and What Comes Next for the Pouch Format
The pouch format itself is genuinely good. It's discreet, fast-absorbing (sublingual delivery bypasses the digestive system for quicker onset), portable, and doesn't require vaping, smoking, or swallowing pills. ZYN and its competitors proved that millions of people prefer this delivery method. Now that we've answered when were ZYNs invented, the more interesting question is what you put inside the pouch.
Roon was built on that exact question. It uses the same sublingual pouch format that ZYN popularized, but replaces nicotine entirely with a stack of four active ingredients: 40mg of Caffeine, L-Theanine, Theacrine, and Methylliberine. The caffeine provides the immediate alertness. L-Theanine smooths it out so you don't get jittery. Theacrine extends the effect to 4-6 hours without the tolerance buildup that nicotine (and even coffee) creates. Methylliberine accelerates onset so you feel it working within minutes.
Zero nicotine. No dependency loop. No escalating dosages.
If the ZYN history shows anything, it's that the format keeps evolving. From snus to Zonnic to ZYN to a market worth billions, each generation solved a problem the last one couldn't. Knowing when were ZYNs invented puts the full timeline in perspective: the pouch concept is barely 17 years old, and it's still changing. Roon is simply the next step: same pouch, better ingredients, built for focus instead of addiction.
See what's inside at takeroon.com.






